Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00448032
What this trial is testing

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

Who this might be right for
Diabetes Mellitus
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT01375387
What this trial is testing

Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males

Who this might be right for
Healthy Volunteers
UCB Pharma 33
Early research (Phase 1)WithdrawnNCT02322606
What this trial is testing

A Phase 1, Single and Multiple Dose Study of TAK-137

Who this might be right for
Healthy Japanese Adult Male
Takeda
Early research (Phase 1)Study completedNCT01894399
What this trial is testing

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
Hanmi Pharmaceutical Company Limited 59
Early research (Phase 1)Study completedNCT01081821
What this trial is testing

Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 61
Early research (Phase 1)Study completedNCT01655056
What this trial is testing

Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+2 more
Astellas Pharma Europe B.V. 82
Early research (Phase 1)Study completedNCT00434187
What this trial is testing

Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 24
Early research (Phase 1)Study completedNCT00752544
What this trial is testing

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

Who this might be right for
HCV
Tibotec Pharmaceuticals, Ireland 30
Early research (Phase 1)Study completedNCT02213315
What this trial is testing

A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese Subjects

Who this might be right for
Healthy Volunteers
MedImmune LLC 39
Early research (Phase 1)Study completedNCT02306915
What this trial is testing

PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants

Who this might be right for
PharmacokineticsPharmacodynamics
Merckle GmbH 48
Early research (Phase 1)Study completedNCT00622830
What this trial is testing

Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-

Who this might be right for
Atherosclerosis
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT03750565
What this trial is testing

Multiple Dose Ethnobridging PK Study in Healthy Subjects

Who this might be right for
Inflammatory Bowel DiseasesIBD
Theravance Biopharma 60
Early research (Phase 1)Study completedNCT02824315
What this trial is testing

Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 22
Early research (Phase 1)Study completedNCT01407016
What this trial is testing

Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects

Who this might be right for
Infection
Pfizer 6
Early research (Phase 1)Study completedNCT01497535
What this trial is testing

Within-subject Variability of Insulin Detemir in Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 40
Early research (Phase 1)Study completedNCT05508204
What this trial is testing

Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects

Who this might be right for
Healthy Volunteer
Chinook Therapeutics, Inc. 36
Early research (Phase 1)Study completedNCT00385489
What this trial is testing

Study Evaluating LXR-623 in Healthy Japanese Adults

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT02039076
What this trial is testing

A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects

Who this might be right for
Thrombocytopenia
Eisai Inc. 48
Early research (Phase 1)Study completedNCT03040635
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants

Who this might be right for
Healthy Volunteers
Hoffmann-La Roche 24
Early research (Phase 1)Study completedNCT02447393
What this trial is testing

Phase 1 Study of Levocetirizine

Who this might be right for
Dermatitis
GlaxoSmithKline 20
Next Page